Sino Biopharmaceutical Limited was listed on the Growth Enterprise Market (GEM) of The Stock Exchange of Hong Kong Limited (Stock Code: 0827)
Sino Biopharmaceutical Ltd was successfully moved to the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 1177)
Sino Biopharmaceutical Ltd Sold one of the Group’s subsidiaries Shandong Chia Tai Freda Pharmaceutical Co., Ltd to Bausch & Lomb for US$200 Million
The Company entered into the medical healthcare business by founding Chia Tai Shaoyang Orthopedic Hospital
Sino Biopharmaceutical Limited entered the health food market by holding Tianjin Zhenwutang Food Co., Ltd.
Sino Biopharmaceutical Limited made its presence in Europe by investing a stake in Karolinska Development AB
Sino Biopharmaceutical Limited's market capital (Stock Code: 1177) surpassed HK$100 Billion.
Sino Biopharmaceutical Limited was selected as a constituent stock of the Hang